Evidence map›Paper›PMID 32048041›Full record

ReviewPlanta2020

The endangered Saharan cypress (Cupressus dupreziana): do not let it get into Charon's boat.

Jana Lábusová, Hana Konrádová, Helena Lipavská

Abstract readReview
PubMed Publisher
In one paragraph

Review in Planta, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jana LábusováDepartment of Experimental Plant Biology, Faculty of Science, Charles University, Viničná 5, 128 43, Prague 2, Czech Republic.
Hana KonrádováDepartment of Experimental Plant Biology, Faculty of Science, Charles University, Viničná 5, 128 43, Prague 2, Czech Republic. hana.konradova@natur.cuni.cz.ORCID http://orcid.org/0000-0003-0431-9425
Helena LipavskáDepartment of Experimental Plant Biology, Faculty of Science, Charles University, Viničná 5, 128 43, Prague 2, Czech Republic.
Charles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MAIN

conclusionThe current state-of-the-art creates a sound basis for the preservation of unique species Cupressus dupreziana provided that targeted effort and care is devoted to the accomplishment of multiplication protocols. This review is to summarize known data on Cupressus dupreziana-specific characteristics, including abiotic stress resistance, and natural reproduction, and estimates the possibilities of ex situ conservation with an emphasis on the cultivation in vitro of this endangered species. As there is only limited information about the cultivation of C. dupreziana in vitro, we have included relevant data on the related species Cupressus sempervirens, where micropropagation techniques are well established, along with other information on species with similar fates and life strategies-Saharan olive Olea europaea subsp. laperrinei and myrtle Myrthus nivellei. The aim of this work is to enhance general understanding and to promote an interest in this relict plant species to contribute to more wide-ranging studies and to increase its chance of preservation. Besides others, reducing the number of species threatened with extinction is an essential and immediate task as high genetic variability of ecosystems is crucial for their stability under changing climatic conditions.

Indexed as

Endangered SpeciesAfrica, NorthernCupressusEcosystemGeographyPlant BreedingReproductionCultivation in vitroDuprez´cypressMicropropagationOlea europaea subsp. laperrineiSaharan relict plant species

Identifiers

PMID32048041
OpenAlexW3005739185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.